Currently, Thomas Plitz holds the position of Chief Executive Officer of Chord Therapeutics SA. Dr. Plitz is also on the board of RELIEF THERAPEUTICS Holding AG.

In the past he held the position of Principal at Serono Corp., Chief Scientific Officer at Wilson Therapeutics AB, Principal at Shire Pharmaceuticals, Inc. and Principal at Merck Serono Ltd.

Thomas Plitz received a doctorate from Technische Universität München.